A Singapore startup is testing its antiviral drug, RetroMAD1, against the SARS-CoV-2 beta-coronavirus that causes COVID-19. A spokesperson for Biovalence Technologies, the company that developed the drug, believes its drug could treat Covid-19. He said several scientific papers had revealed that a specific mutation of Sars-CoV-2 bears similarity to how dengue, Ebola, FeCoV and … [Read more...]